Pharma Industry Urges UK To Make Good On Its Clinical Trial Promises

 
• By Vibha Sharma

Research-based drug companies are asking for swift implementation of UK clinical trial reforms to ensure the country does not lose out on commercial trial activity amid challenges such as capacity constraints in the NHS and delays in regulatory approvals.

Blue scrubs with UK British flag for NHS medical workers under enormous strain due to coronavirus epidemic
Lack Of NHS Capacity Is A Key Reason Behind Declining Industry Trials In The UK • Source: Shutterstock

More from United Kingdom

More from Europe